These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8229781)

  • 1. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections.
    Martin TJ; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
    Martin TJ; Dworkin SI; Smith JE
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections.
    Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR
    Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
    Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW; Liu-Chen LY
    J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
    Mjanger E; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence.
    Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW
    J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H] beta-funaltrexamine ([3H] beta-FNA) binds irreversibly to mu opioid receptors in the rat brain: autoradiographic study.
    Liu-Chen LY; Li SX; Rohrbach KW; Lewis ME
    Prog Clin Biol Res; 1990; 328():61-4. PubMed ID: 2154819
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution.
    Liu-Chen LY; Li SX; Lewis ME
    Brain Res; 1991 Mar; 544(2):235-42. PubMed ID: 1645609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain.
    Fitzgerald LW; Teitler M
    Synapse; 1993 Jun; 14(2):154-9. PubMed ID: 8392757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    Liu-Chen LY; Li SX; Tallarida RJ
    Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
    Burke TF; Woods JH; Lewis JW; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections.
    Martin TJ; DeMontis MG; Kim SA; Sizemore GM; Dworkin SI; Smith JE
    Drug Alcohol Depend; 1998 Oct; 52(2):135-47. PubMed ID: 9800143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE; Hammond DL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.